Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
- PMID: 39771483
- PMCID: PMC11728517
- DOI: 10.3390/pharmaceutics16121504
Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
Abstract
Inflammation and apoptosis are interrelated biological processes that have a significant impact on the advancement and growth of certain chronic diseases, such as cardiovascular problems, neurological conditions, and osteoarthritis. Recent research has emphasized that focusing on these mechanisms could result in novel therapeutic approaches that aim to decrease the severity of diseases and enhance patient outcomes. Hydroxytyrosol (HT), which is well-known for its ability to prevent oxidation, has been identified as a possible candidate for regulating both inflammation and apoptosis. In this review, we will highlight the multifaceted benefits of HT as a therapeutic agent in mitigating inflammation, apoptosis, and associated conditions. This review provides a comprehensive overview of the latest in vitro and in vivo research on the anti-inflammatory and antiapoptotic effects of HT and the mechanisms by which it works. Based on these studies, it is strongly advised to use HT as a bioactive ingredient in pharmaceutical products intended for mitigating inflammation, as well as those with apoptosis applications.
Keywords: apoptosis; hydroxytyrosol; inflammation; natural products.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Hydroxytyrosol protects against cisplatin-induced nephrotoxicity via attenuating CKLF1 mediated inflammation, and inhibiting oxidative stress and apoptosis.Int Immunopharmacol. 2021 Jul;96:107805. doi: 10.1016/j.intimp.2021.107805. Epub 2021 May 28. Int Immunopharmacol. 2021. PMID: 34162164
-
Hydroxytyrosol prevents dermal papilla cells inflammation under oxidative stress by inducing autophagy.J Biochem Mol Toxicol. 2019 Sep;33(9):e22377. doi: 10.1002/jbt.22377. Epub 2019 Jul 23. J Biochem Mol Toxicol. 2019. PMID: 31332898
-
Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.Daru. 2019 Jun;27(1):283-293. doi: 10.1007/s40199-019-00274-3. Epub 2019 May 26. Daru. 2019. PMID: 31129807 Free PMC article.
-
Hydroxytyrosol: Its role in the prevention of cardiovascular diseases.Heliyon. 2023 Jan 13;9(1):e12963. doi: 10.1016/j.heliyon.2023.e12963. eCollection 2023 Jan. Heliyon. 2023. PMID: 36704293 Free PMC article. Review.
-
Hydroxytyrosol: Bioavailability, toxicity, and clinical applications.Food Res Int. 2018 Mar;105:654-667. doi: 10.1016/j.foodres.2017.11.053. Epub 2017 Nov 21. Food Res Int. 2018. PMID: 29433260 Review.
Cited by
-
Impact of pharmacokinetic enhancement strategies on the antimicrobial and antioxidant activities of hydroxytyrosol.RSC Adv. 2025 Feb 3;15(5):3448-3464. doi: 10.1039/d4ra08205b. eCollection 2025 Jan 29. RSC Adv. 2025. PMID: 39902104 Free PMC article.
-
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review.Front Pharmacol. 2025 Apr 16;16:1560567. doi: 10.3389/fphar.2025.1560567. eCollection 2025. Front Pharmacol. 2025. PMID: 40308781 Free PMC article. Review.
-
Design, Synthesis, and Biological Evaluation of Novel Hydroxytyrosol Derivatives as Protectors for Vascular Endothelium Against Lipid Overload.Drug Des Devel Ther. 2025 Apr 1;19:2433-2452. doi: 10.2147/DDDT.S500670. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40190807 Free PMC article.
-
Enhanced Thermal Resilience of Olive Oils: Fatty Acid Dynamics with Polyphenols Supplementation.Foods. 2025 Jun 13;14(12):2085. doi: 10.3390/foods14122085. Foods. 2025. PMID: 40565694 Free PMC article.
-
Early-stage administration of hydroxytyrosol extends lifespan and delays aging in C. elegans.Biol Direct. 2025 May 21;20(1):62. doi: 10.1186/s13062-025-00634-x. Biol Direct. 2025. PMID: 40399944 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources